XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has released comments on recent promotional activity. XPhyto released the comments at the request of OTC Markets. In the comments, XPhyto noted that it was listed on the Canadian Securities Exchange in July 2019 and since that time has worked with a variety of third-party companies to provide promotional activities that include media, marketing and investor relations services. Earlier this month, XPhyto engaged Investor Channel Inc. to provide advertising placements and transaction services. In the process of doing so, all source materials and content for all promotional activity were provided by and vetted for factual accuracy by a senior officer of the corporation, and payment for all promotional activity was made by the corporation exclusively. XPhyto’s executive management participated in the creation of promotional materials but was not involved in the distribution of promotional materials. While XPhyto ultimately had control over all promotional activities, all promotional activities were executed according to written or oral agreements with third-party providers along with associated subcontractors.
To view the full press release, visit https://ibn.fm/y3ubD
About XPhyto Therapeutics Corp.
XPhyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral-health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. XPhyto has research and development operations in North America and Europe, with an operational focus in Germany, and the company is currently focused on regulatory approval and commercialization of medical products for European markets. For more information about this company, please visit www.XPhyto.com
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
InvestorWire is part of the InvestorBrandNetwork.